Entity Common Stock, Shares Outstanding of BIOADAPTIVES, INC. from 12 Aug 2013 to 17 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
BIOADAPTIVES, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 Aug 2013 to 17 Oct 2025.
  • BIOADAPTIVES, INC. Entity Common Stock, Shares Outstanding for the quarter ending 17 Oct 2025 was 12,008,659, a 99% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

BIOADAPTIVES, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 12,008,659 -1,219,720,315 -99% 17 Oct 2025 10-Q 14 Nov 2025 2025 Q3
Q1 2025 9,048,659 -963,111,982 -99% 21 Mar 2025 10-K 15 Apr 2025 2024 FY
Q4 2024 1,231,728,974 15 Nov 2024 10-Q 19 Nov 2024 2024 Q3
Q3 2024 1,231,728,974 +455,264,951 +59% 15 Aug 2024 10-Q 19 Aug 2024 2024 Q2
Q2 2024 1,174,774,530 +398,310,507 +51% 17 May 2024 10-Q 17 May 2024 2024 Q1
Q1 2024 972,160,641 +616,528,075 +173% 22 Mar 2024 10-K 10 Apr 2024 2023 FY
Q3 2023 776,464,023 +615,976,512 +384% 08 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 776,464,023 +672,650,568 +648% 10 Aug 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 355,632,566 +299,902,677 +538% 24 Mar 2023 10-K 31 Mar 2023 2022 FY
Q3 2022 160,487,511 +121,708,832 +314% 07 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 103,813,455 +70,791,030 +214% 10 Aug 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 55,729,889 +22,707,464 +69% 20 Mar 2022 10-K 31 Mar 2022 2021 FY
Q3 2021 38,778,679 +18,695,396 +93% 05 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 33,022,425 +14,446,046 +78% 08 Aug 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 33,022,425 30 Mar 2021 10-K 30 Mar 2021 2020 FY
Q3 2020 20,083,283 +1,254,174 +6.7% 27 Oct 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 18,576,379 0 0% 29 May 2020 10-Q/A 11 Jun 2020 2020 Q1
Q4 2019 18,576,379 31 Dec 2019 10-K/A 12 May 2020 2019 FY
Q3 2019 18,829,109 05 Nov 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 18,576,379 12 Aug 2019 10-Q 14 Aug 2019 2019 Q2
Q3 2016 14,180,456 +1,444,020 +11% 18 Aug 2016 10-Q 18 Aug 2016 2016 Q2
Q2 2016 14,180,456 +1,444,020 +11% 23 May 2016 10-Q 23 May 2016 2016 Q1
Q1 2016 12,736,436 +100,000 +0.79% 14 Apr 2016 10-K 14 Apr 2016 2015 FY
Q3 2015 12,736,436 +100,000 +0.79% 30 Sep 2015 10-Q 23 Nov 2015 2015 Q3
Q2 2015 12,736,436 +100,000 +0.79% 30 Jun 2015 10-Q 21 Aug 2015 2015 Q2
Q1 2015 12,636,436 +594,769 +4.9% 08 Apr 2015 10-K 15 Apr 2015 2014 FY
Q3 2014 12,636,436 +2,636,436 +26% 14 Nov 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 12,636,436 +2,636,436 +26% 14 Aug 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 12,041,667 31 Mar 2014 10-K 14 Apr 2014 2013 FY
Q3 2013 10,000,000 21 Oct 2013 10-Q 21 Oct 2013 2013 Q3
Q2 2013 10,000,000 12 Aug 2013 10-Q 13 Aug 2013 2013 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.